Abstract
The International Dermatology Outcome Measures (IDEOM) group was formed to enhance outcomes and facilitate access to dermatologic care by creating standardized measures of disease progression and treatment efficacy that emphasize the perspectives of patients and the others involved. With these goals in mind, IDEOM enabled patients, physicians, health economists from participating pharmaceutical industries, payers, and regulatory agencies to create validated measures for use in both clinical trials and clinical practice.
| Original language | English |
|---|---|
| Pages (from-to) | 1027-1028 |
| Number of pages | 2 |
| Journal | Journal of Rheumatology |
| Volume | 42 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1 Jun 2015 |
| Externally published | Yes |
Keywords
- DERMATOLOGY
- IDEOM
- OMERACT
- OUTCOME MEASURES
- PSORIASIS
Fingerprint
Dive into the research topics of 'The international dermatology outcome measures group: Update from the GRAPPA 2014 annual meeting'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver